Cargando…
Preclinical and clinical applications of specific molecular imaging for HER2-positive breast cancer
Precision medicine and personalized therapy are receiving increased attention, and molecular-subtype classification has become crucial in planning therapeutic schedules in clinical practice for patients with breast cancer. Human epidermal growth factor receptor 2 (HER2) is associated with high-grade...
Autores principales: | Chen, Wei, Li, Xiaofeng, Zhu, Lei, Liu, Jianjing, Xu, Wengui, Wang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570603/ https://www.ncbi.nlm.nih.gov/pubmed/28884043 http://dx.doi.org/10.20892/j.issn.2095-3941.2017.0044 |
Ejemplares similares
-
(18)F-FHBG PET-CT Reporter Gene Imaging of Adoptive CIK Cell Transfer Immunotherapy for Breast Cancer in a Mouse Model
por: Li, Xiaofeng, et al.
Publicado: (2020) -
Predictive Power of a Radiomic Signature Based on (18)F-FDG PET/CT Images for EGFR Mutational Status in NSCLC
por: Li, Xiaofeng, et al.
Publicado: (2019) -
Preclinical Assessment of Paclitaxel- and Trastuzumab-Delivering Magnetic Nanoparticles Fe(3)O(4) for Treatment and Imaging of HER2-Positive Breast Cancer
por: Guo, Liting, et al.
Publicado: (2021) -
Enhanced glucose metabolism mediated by CD147 is associated with (18)F‐FDG PET/CT imaging in lung adenocarcinoma
por: Zhang, Yufan, et al.
Publicado: (2020) -
Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors
por: Zhu, Lei, et al.
Publicado: (2020)